Harrow Inc (HROW)
44.07
-0.16
(-0.36%)
USD |
NASDAQ |
Sep 27, 16:00
44.01
-0.06
(-0.14%)
After-Hours: 20:00
Harrow SG&A Expense (TTM): 107.88M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 107.88M |
March 31, 2024 | 96.02M |
December 31, 2023 | 83.09M |
September 30, 2023 | 72.12M |
June 30, 2023 | 66.50M |
March 31, 2023 | 60.73M |
December 31, 2022 | 58.24M |
September 30, 2022 | 55.68M |
June 30, 2022 | 51.61M |
March 31, 2022 | 46.55M |
December 31, 2021 | 41.32M |
September 30, 2021 | 36.08M |
June 30, 2021 | 33.16M |
March 31, 2021 | 31.00M |
December 31, 2020 | 31.25M |
September 30, 2020 | 31.50M |
June 30, 2020 | 31.67M |
March 31, 2020 | 32.96M |
December 31, 2019 | 33.09M |
September 30, 2019 | 34.41M |
June 30, 2019 | 32.77M |
March 31, 2019 | 31.30M |
December 31, 2018 | 29.24M |
September 30, 2018 | 26.17M |
June 30, 2018 | 24.99M |
Date | Value |
---|---|
March 31, 2018 | 24.70M |
December 31, 2017 | 25.02M |
September 30, 2017 | 24.71M |
June 30, 2017 | 25.74M |
March 31, 2017 | 25.92M |
December 31, 2016 | 24.95M |
September 30, 2016 | 25.54M |
June 30, 2016 | 23.64M |
March 31, 2016 | 21.35M |
December 31, 2015 | 19.00M |
September 30, 2015 | 15.63M |
June 30, 2015 | 13.31M |
March 31, 2015 | 11.69M |
December 31, 2014 | 10.48M |
September 30, 2014 | 9.508M |
June 30, 2014 | 8.540M |
March 31, 2014 | 7.338M |
December 31, 2013 | 6.081M |
September 30, 2013 | 4.939M |
June 30, 2013 | 4.263M |
March 31, 2013 | 3.691M |
December 31, 2012 | 2.980M |
September 30, 2012 | 2.553M |
June 30, 2012 | 1.673M |
March 31, 2012 | 0.81M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
31.00M
Minimum
Mar 2021
107.88M
Maximum
Jun 2024
51.74M
Average
43.93M
Median
SG&A Expense (TTM) Benchmarks
Omeros Corp | 53.37M |
Amphastar Pharmaceuticals Inc | 88.15M |
PetIQ Inc | 208.04M |
Alector Inc | 57.09M |
Outset Medical Inc | 132.37M |